AnalystsInsight

Chase Knickerbocker (Craig-Hallum): Analyst Track Record and Price‑Target Accuracy

How often Chase Knickerbocker’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 1,080 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

Key takeaways

  • Chase Knickerbocker ranks #112 of 1,000 analysts in Exent’s scoring (5.0★).
  • 35.8% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 117 days; 57.5% of calls were up 12 months later.
  • Most‑covered stocks: BFLY, ETON, MDXG, HROW.

Chase Knickerbocker’s track record at a glance

Chase Knickerbocker of Craig-Hallum ranks #112 of the 1,000 analysts Exent scores, with a 5.0★ rating and a focus on healthcare. Over a 7‑year lookback, 35.8% of Chase’s price targets were reached, 16.6 points below the 52.4% average across all analysts.

MetricChase KnickerbockerAll analysts
Price‑target hit rate35.8%52.4%
Median days to hit target117 days91 days
Calls up after 12 months57.5%64.0%
Median 12‑month return of calls+11.2%+13.4%
Hit rate, last 2 years34.6%—
Average worst drop after a call−27.7%—
Ratings in the sample1,080—
Stocks covered43—

How fast price targets were reached

Time to reach the targetChase Knickerbocker
Under 30 days8.0%
30–90 days32.0%
90–180 days32.0%
Over 180 days28.0%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Chase Knickerbocker covers most

StockRatings in the sample
BFLY28
ETON28
MDXG27
HROW27
CVRX25
XERS23
DCTH19
BVS19

In the past year Chase’s ratings were 99% Buy, 1% Hold and 0% Sell.

Recent ratings (shown with a 30-day delay)

DateStockActionRatingPrice target
Sep 17, 2026INDVReiterated: BuyBuy$0.00
Sep 17, 2026NRXSRated: BuyBuy$13.00
Sep 10, 2026XERSRated: BuyBuy$12.00
Sep 8, 2026MDXGReiterated: BuyBuy$8.00
Sep 2, 2026GUTSReiterated: BuyBuy$4.00
Sep 2, 2026BFLYReiterated: BuyBuy$10.00
Aug 18, 2026BFLYReiterated: BuyBuy$10.00
Aug 18, 2026CELCReiterated: BuyBuy$173.00
Aug 18, 2026GRCEReiterated: BuyBuy$4.00
Aug 14, 2026ETONReiterated: BuyBuy$76.00
Aug 14, 2026ACOGReiterated: BuyBuy$17.00
Aug 12, 2026FENCRated: BuyBuy$18.00
  • Sep 17, 2026
    Stock
    INDV
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $0.00
  • Sep 17, 2026
    Stock
    NRXS
    Action
    Rated: Buy
    Rating
    Buy
    Price target
    $13.00
  • Sep 10, 2026
    Stock
    XERS
    Action
    Rated: Buy
    Rating
    Buy
    Price target
    $12.00
  • Sep 8, 2026
    Stock
    MDXG
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $8.00
  • Sep 2, 2026
    Stock
    GUTS
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $4.00
  • Sep 2, 2026
    Stock
    BFLY
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $10.00
  • Aug 18, 2026
    Stock
    BFLY
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $10.00
  • Aug 18, 2026
    Stock
    CELC
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $173.00
  • Aug 18, 2026
    Stock
    GRCE
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $4.00
  • Aug 14, 2026
    Stock
    ETON
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $76.00
  • Aug 14, 2026
    Stock
    ACOG
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $17.00
  • Aug 12, 2026
    Stock
    FENC
    Action
    Rated: Buy
    Rating
    Buy
    Price target
    $18.00

Live ratings from Chase Knickerbocker and the other top‑ranked analysts, and the stocks where they agree, are in Exent Stocks Radar.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 19, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Stocks Radar shows Chase Knickerbocker’s live ratings and those of the other top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Chase Knickerbocker ranks #112 of 1,000 with a 5.0★ rating. 35.8% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 57.5% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Chase Knickerbocker’s success rate is 55.6% by the ranking source and 35.8% by Exent’s price-target hit-rate backtest, with a median of 117 days to reach a target.

Chase Knickerbocker (Craig-Hallum) covers 43 stocks, mostly in healthcare. The most frequently rated are BFLY, ETON, MDXG, HROW, CVRX.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.